Client NewsCompany News Avance Clinical Client Atossa Therapeutics Announces Enrollment and Dosing Completed in First Group of Healthy Participants in Clinical Study of AT-301 Nasal Spray Being Developed for Treatment of COVID-19 The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership…News EditorAugust 27, 2020
Other news Mike Watson Appointed Avance Clinical Director, Business Development, USA Mike Watson has joined Avance Clinical as Director, Business Development, USA. It is our pleasure…News EditorAugust 12, 2020
Company NewsPartner News Avance Clinical Joins Medrio’s ‘Trial Talks’ Podcast about Why Clinical Trials are Thriving in Australia The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner…News EditorJuly 30, 2020
Client NewsCompany News Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa’s Second COVID-19 Therapeutic Development Program The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner…News EditorJuly 22, 2020
Company Awards Soniclean is proud to announce Avance Clinical as the winner of the International Health Award at the Business SA 2019 Export Awards As a major sponsor, Soniclean is thrilled to be able to celebrate South Australian exporting…News EditorJuly 13, 2020